Advances in auditory and vestibular medicine

Audiological Medicine

Volumn 7, Issue 4, 2009, Pages 180-188

  Hamid, Mohamed A ^a   Trune, Dennis R ^b   Dutia, Mayank B ^c  

^a Cleveland Hearing and Balance Center   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Auditory and vestibular medicine; BPPV; Hearing loss; Intratympanic perfusion; Ion homeostasis of the inner ear; M ni re?s disease; Vertigo; Vestibular compensation; Vestibular m graine; Vestibular rehabilitation

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEXAMETHASONE; DIURETIC AGENT; GENTAMICIN; GLYCINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; POTASSIUM; PREDNISONE; STEROID; TRIPTAN DERIVATIVE;

AUDIOMETRY; AUDITORY AND VESTIBULAR MEDICINE; AUDITORY REHABILITATION; BLOOD EXAMINATION; BREATHING EXERCISE; CEREBELLUM; COCHLEA PROSTHESIS; COGNITIVE THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL DEAFNESS; DIAGNOSTIC TEST; DIZZINESS; ELECTRONYSTAGMOGRAPHY; ELECTROPHYSIOLOGY; EYE MOVEMENT; GAIT; GENE THERAPY; HEARING AID; HEARING DISORDER; HEARING LOSS; HOMEOSTASIS; HUMAN; HYPERVENTILATION SYNDROME; INNER EAR; INNER EAR DISEASE; MEDICAL DECISION MAKING; MEDICINE; MENIERE DISEASE; MIGRAINE; NECK; NERVE CELL; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NOISE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OCCUPATIONAL THERAPY; PATHOPHYSIOLOGY; PATIENT CARE; PHYSIOTHERAPY; POTASSIUM TRANSPORT; PRESBYACUSIS; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SODIUM RESTRICTION; SPEECH REHABILITATION; STRESS; STRESS MANAGEMENT; SUDDEN DEAFNESS; TINNITUS; VERTIGO; VESTIBULAR DISORDER; VESTIBULAR EVOKED MYOGENIC POTENTIAL; VESTIBULAR FUNCTION; VESTIBULAR MIGRAINE; VESTIBULAR NEURONITIS; VESTIBULAR NUCLEUS; VESTIBULAR TEST; VESTIBULOCOCHLEAR NERVE DISEASE; VESTIBULOOCULAR REFLEX;

EID: 70450179717     PISSN: 1651386X     EISSN: 16513835     Source Type: Journal    
DOI: 10.3109/02841860903364076     Document Type: Review

References (67)

1. Gabashvili IS, Sokolowski BH, Morton CC, Giersch AB. Ion channel gene expression in the inner ear. J Assoc Res Otolaryngol. 2007;8:305-328
2. Hibino H, Kurachi Y. Molecular and physiological bases of the K+ circulation in the mammalian inner ear. Physiology (Bethesda). 2006;21:336-345
3. Lang F, Vallon V, Knipper M, Wangemann P. Functional signifi cance of channels and transporters expressed in the inner ear and kidney. Am J Physiol Cell Physiol. 2007;293: 1187-1208.
4. Trune DR. Ion Homeostasis and Inner Ear Disease. In: Hamid MA, Sismanis A (editors). Medical Otology and Neurotology. A Medical GuiDe to Auditory and Vestibular Disorders. New York: Thieme; 2006. p. 21-23
5. Huang D, Chen P, Chen S, Nagura M, Lim DJ, Lin X. Expression patterns of aquaporins in the inner ear: Evidence for concerted actions of multiple types of aquaporins to facilitate water transport in the cochlea. Hear Res. 2002; 165:85-95.
6. Beitz E, Zenner HP, Schultz JE. Aquaporin mediated fl uid regulation in the inner ear. Cell Mol Neurobiol.2003; 23:315-329
7. Boone RT, Zuo C, Fan CY, Dornhoffer J. Modifi cation of atrial natriuretic peptiDe receptor expression in the rat inner ear. Otol Neurotol. 2005;26:534-537
8. Taguchi D, Takeda T, Kakigi A, Takumida M, Nishioka R, Kitano H. Expressions of aquaporin-2, vasopressin type 2 receptor, transient receptor potential channel vanilloid (TRPV)1, and TRPV4 in the human endolymphatic sac. Laryngoscope. 2007;117:695-698
9. Weber PC, Cunningham CD III, Schulte BA. Potassium recycling pathways in the human cochlea. Laryngoscope. 2001;111:1156-1165
10. Brandt N, Kuhn S, Munkner S, Braig C, Winter H, Blin N, et al. Thyroid hormone defi ciency affects postnatal spiking activity and expression of Ca2+ and K+ channels in rodent inner hair cells. J Neurosci. 2007;27:3174-3186
11. Qu C, Liang F, Smythe NM, Schulte BA. Identifi cation of ClC-2 and CIC-K2 chloriDe channels in cultured rat type 4 spiral ligament fi brocytes. J Assoc Res Otolaryngol. 2007; 8:205-219
12. Lee JH, Marcus DC. Purinergic signaling in the inner ear. Hear Res. 2008;235:1-7.
13. Lalwani AK, Castelein CM. Cracking the auditory genetic code: Non-syndromic hereditary hearing impairment. Am J Otol. 1999;20:115-132
14. Nance WE. The genetics of deafness. Ment Retard Dev Disabil Res Rev. 2003;9:109-119
15. Van Laer L, Cryns K, Smith RJ, Van Camp G. Non-syndromic hearing loss. Ear Hear. 2003;24:275-288
16. Spicer SS, Schulte BA. Evidence for a medial K+ recycling pathway from inner hair cells. Hear Res. 1998;118:1-12.
17. Chiba T, Marcus DC. Non-selective cation and BK channels in apical membrane of outer sulcus epithelial cells. J Membr Biol. 2000;174:167-179
18. Jentsch TJ. Neuronal KCNQ potassium channels: Physiology and role in disease. Nat Rev Neurosci. 2000;1:21-30.
19. Chang EH, Van Camp G, Smith RJ. The role of connexins in human disease. Ear Hear. 2003;24:314-323
20. Couloigner V, Sterkers O, Ferrary E. What's new in ion transports in the cochlea? Pflugers Arch. 2006;453:11-22.
21. Nickel R, Forge A. Gap junctions and connexins in the inner ear: Their roles in homeostasis and deafness. Curr Opin Otolaryngol Head Neck Surg. 2008;16:452-457
22. Yan D, Liu XZ. Cochlear molecules and hereditary deafness. Front Biosci. 2008;13:4972-4983
23. Spiess AC, Lang H, Schulte BA, Spicer SS, Schmiedt RA. Effects of gap junction uncoupling in the gerbil cochlea. Laryngoscope. 2002;112:1635-1641
24. Cohen-Salmon M, Regnault B, Cayet N, Caille D, Demuth K, Hardelin JP, et al. Connexin 30 defi ciency causes instrastrial fl uid-blood barrier disruption within the cochlear stria vascularis. Proc Natl Acad Sci U S A. 2007;104:6229-6234
25. Takeuchi S, Ando M. Dye-coupling of melanocytes with endothelial cells and pericytes in the cochlea of gerbils. Cell Tissue Res. 1998;293:271-275
26. Tadros SF, Frisina ST, Mapes F, Frisina DR, Frisina RD. Higher serum aldosterone correlates with lower hearing thresholds: A possible protective hormone against presbycusis. Hear Res. 2005;209:10-18
27. Trune DR, Kempton JB, Gross ND. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res. 2006;212:22-32.
28. Kim SH, Kim KX, Raveendran NN, Wu T, Pondugula SR, Marcus DC. Regulation of ENaC-mediated sodium transport by glucocorticoids in Reissner's membrane epithelium. Am J Physiol Cell Physiol. 2009;296:544-557
29. Trune DR BK. Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid restoration of autoimmune mouse hearing loss. Audiol Neurotol 2009. (in Press.)
30. Wangemann P. Comparison of ion transport mechanisms between vestibular dark cells and strial marginal cells. Hear Res. 1995;90:149-157
31. Sage CL, Marcus DC. Immunolocalization of ClC-K chloriDe channel in strial marginal cells and vestibular dark cells. Hear Res. 2001;160:1-9.
32. Milhaud PG, Pondugula SR, Lee JH, Herzog M, Lenouelleur J, Wangemann P, et al. ChloriDe secretion by semicircular canal duct epithelium is stimulated via beta 2-adrenergic receptors. Am J Physiol Cell Physiol. 2002;283:1752-1760
33. Curthoys IS. Vestibular compensation and substitution. Curr Opin Neurol. 2000;13:27-30.
34. Paterson JM, Menzies JRW, Bergquist F, Dutia MB. Cellular mechanisms of vestibular compensation. Neuroembryol Aging. 2006;3:3183-3193
35. Paterson JM, Short D, Flatman PW, Seckl JR, Aitken A, Dutia MB. Changes in protein expression in the rat medial vestibular nuclei during vestibular compensation. J Physiol. 2006;575:777-788
36. Seemungal BM, Gresty MA, Bronstein AM. The endocrine system, vertigo and balance. Curr Opin Neurol. 2001;14: 27-34.
37. Lindsay L, Liu P, Gliddon C, Zheng Y, Smith PF, Darlington CL. Cytosolic glucocorticoid receptor expression in the rat vestibular nucleus and hippocampus following unilateral vestibular deafferentation. Exp Brain Res. 2005;162:309-314
38. Zhang R, Smith PF, Darlington CL. Immunocytochemical and stereological study of glucocorticoid receptors in rat medial vestibular nucleus neurons and the effects of unilateral vestibular deafferentation. Acta Otolaryngol. 2005;125: 1258-1264 (Pubitemid 41721988)
39. Guilding C, Seckl JR, Dutia MB. 11Beta-hydroxysteroid dehydrogenase type 1 activity in medial vestibular nucleus and cerebellum after unilateral vestibular deafferentation in the rat. Stress. 2004;7:127-130
40. Gliddon CM, Smith PF, Darlington CL. Interaction between the hypothalamic-pituitary-adrenal axis and behavioural compensation following unilateral vestibular deafferentation. Acta Otolaryngol. 2003;123:1013-1021
41. Kitahara T, Kondoh K, Morihana T, Okumura S, Horii A, Takeda N, et al. Steroid effects on vestibular compensation in human. Neurol Res. 2003;25:287-291
42. Johnston AR, Seckl JR, Dutia MB. Role of the flocculus in mediating vestibular nucleus neuron plasticity during vestibular compensation in the rat. J Physiol. 2002;545:903-911
43. Strupp M, Arbusow V, Brandt T. Exercise and drug therapy alter recovery from labyrinth lesion in humans. Ann N Y Acad Sci. 2001;942:79-94.
44. Hamid M, Samy H. Vestibular and Balance Rehabilitation. In: Hamid M, Sismanis A (editors). Medical Otology and Neurotology. A Clinical GuiDe to Auditory and Vestibular Disorders. New York: Thieme; 2006. p. 94-101.
45. BriganDe JV. Regenerative Medicine for Inner Ear Disease. In: Hamid MA, Sismanis A (editors). Medical Otology and Neurotology. A Medical GuiDe to Auditory and Vestibular Disorders. New York: Thieme; 2006. p. 33-42.
46. Snoecks RL, Van Camp G. Non-syndromic hearing loss: Cracking the cochlear code. In: Martini A (editor). Genes, Hearing, and Deafness: From Molecular Biology to Clinical Practice. London UK: Informa; 2007. p. 63-90.
47. Rubel EW, Oesterle EC, Weisleder P. Hair cell regeneration in the avian inner ear. Ciba Found Symp. 1991;160:77-96.
48. Diensthuber M, Oshima K, Heller S. Stem/progenitor cells derived from the cochlear sensory epithelium give rise to spheres with distinct morphologies and features. J Assoc Res Otolaryngol. 2009;10:173-190
49. Kesser BW, Lalwani AK. Gene therapy and stem cell transplantation: Strategies for hearing restoration. Adv Otorhinolaryngol. 2009;66:64-86.
50. McCullar JS, Oesterle EC. Cellular targets of estrogen signaling in regeneration of inner ear sensory epithelia. Hear Res. 2009;252:61-70.
51. Fu Y, Wang SQ, Wang JT, Wang GP, Xie J, Gong SS. Experimental study on embryonic neural stem cells transplantation into natural rat cochlea via round window. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008;43:944-949
52. Hamid M, Sismanis A. Clinical approach to patients with auditory and vestibular disorders. In: Hamid M, Sismanis A (editors). Medical Otology and Neurotology. A Clinical GuiDe to Auditory and Vestibular Disorders. New York: Thieme; 2006. p. 43-63.
53. Lazarini PR, Camargo AC. Idiopathic sudden sensorineural hearing loss: Etiopathogenic aspects. Rev Bras Otorrinolaringol (Engl Ed). 2006;72:554-561
54. Narozny W, Kuczkowski J, Kot J, Stankiewicz C, Sicko Z, Mikaszewski B. Prognostic factors in sudden sensorineural hearing loss: Our experience and a review of the literature. Ann Otol Rhinol Laryngol. 2006;115:553-558
55. Bamiou DE, Musiek FE, Luxon LM. Etiology and clinical presentations of auditory processing disorders: A review. Arch Dis Child. 2001;85:361-365
56. Lempert T, Neuhauser H, Daroff RB. Vertigo as a symptom of migraine. Ann N Y Acad Sci. 2009;1164:242-251
57. Neuhauser H, Lempert T. Vestibular migraine. Neurol Clin. 2009;27:379-391
58. Neuhauser HK. Epidemiology of dizziness and vertigo. Nervenarzt. 2009;80:887-894
59. Sismanis A. Diagnostic and management dilemma of sudden hearing loss. Arch Otolaryngol Head Neck Surg. 2005;131: 733-734
60. Baldassari CM, Schmidt C, Schubert CM, Srinivasan P, Dodson KM, Sismanis A. Receptive language outcomes in children after cochlear implantation. Otolaryngol Head Neck Surg. 2009;140:114-119
61. Pfister M, Lalwani AK. Gene therapy of the inner ear. In: Martini A (editor). Genes, Hearing, and Deafness: From Molecular Biology to Clinical Practice. London, UK: Informa; 2007. p. 299-304.
62. Hamid MA. The Maneuvers for BPPV. Operative Techniques in Otolaryngol Head Neck Surg. 2001;12:148-150
63. Hamid MA. Ménière's disease. Pract Neurol. 2009;9:157-162
64. Hamid M, Trune D. Issues, indications, and controversies regarding intra-tympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg. 2008;16:434-440
65. Hughes GB, Barna BP, Kinney SE, Calabrese LH, Hamid MA, Nalepa NJ. Autoimmune endolymphatic hydrops: Five-year review. Otolaryngol Head Neck Surg. 1988;98:221-225
66. Garcia-Berrocal JR, Ramirez-Camacho R, Trinidad A. Autoimmune hearing loss: Improving diagnostic performance. Acta Otorrinolaringol Esp. 2007;58:138-142
67. Salley LH Jr, Grimm M, Sismanis A, Spencer RF, Wise CM. Methotrexate in the management of immune mediated cochleovestibular disorders: Clinical experience with 53 patients. J Rheumatol. 2001;28:1037-1040